Cargando…
Vaccination strategies for Korean patients with inflammatory bowel disease
Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable infectious diseases. Immunosuppressive drugs, which are often used to manage IBD, may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449215/ https://www.ncbi.nlm.nih.gov/pubmed/35934888 http://dx.doi.org/10.3904/kjim.2022.149 |
_version_ | 1784784244452622336 |
---|---|
author | Lee, Yoo Jin Kim, Eun Soo |
author_facet | Lee, Yoo Jin Kim, Eun Soo |
author_sort | Lee, Yoo Jin |
collection | PubMed |
description | Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable infectious diseases. Immunosuppressive drugs, which are often used to manage IBD, may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and schedule vaccinations for them to reduce the infection-related burden of patients with IBD. All patients with IBD should be assessed in terms of immunity to vaccine-preventable diseases at the time of IBD diagnosis, and be vaccinated appropriately. Vaccination is becoming more important because of the unprecedented coronavirus disease 2019 (COVID-19) global health crisis. This review focuses on recent updates to vaccination strategies for Korean patients with IBD. |
format | Online Article Text |
id | pubmed-9449215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Korean Association of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-94492152022-09-14 Vaccination strategies for Korean patients with inflammatory bowel disease Lee, Yoo Jin Kim, Eun Soo Korean J Intern Med Review Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable infectious diseases. Immunosuppressive drugs, which are often used to manage IBD, may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and schedule vaccinations for them to reduce the infection-related burden of patients with IBD. All patients with IBD should be assessed in terms of immunity to vaccine-preventable diseases at the time of IBD diagnosis, and be vaccinated appropriately. Vaccination is becoming more important because of the unprecedented coronavirus disease 2019 (COVID-19) global health crisis. This review focuses on recent updates to vaccination strategies for Korean patients with IBD. Korean Association of Internal Medicine 2022-09 2022-08-08 /pmc/articles/PMC9449215/ /pubmed/35934888 http://dx.doi.org/10.3904/kjim.2022.149 Text en Copyright © 2022 The Korean Association of Internal Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Lee, Yoo Jin Kim, Eun Soo Vaccination strategies for Korean patients with inflammatory bowel disease |
title | Vaccination strategies for Korean patients with inflammatory bowel disease |
title_full | Vaccination strategies for Korean patients with inflammatory bowel disease |
title_fullStr | Vaccination strategies for Korean patients with inflammatory bowel disease |
title_full_unstemmed | Vaccination strategies for Korean patients with inflammatory bowel disease |
title_short | Vaccination strategies for Korean patients with inflammatory bowel disease |
title_sort | vaccination strategies for korean patients with inflammatory bowel disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449215/ https://www.ncbi.nlm.nih.gov/pubmed/35934888 http://dx.doi.org/10.3904/kjim.2022.149 |
work_keys_str_mv | AT leeyoojin vaccinationstrategiesforkoreanpatientswithinflammatoryboweldisease AT kimeunsoo vaccinationstrategiesforkoreanpatientswithinflammatoryboweldisease |